This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Marco Zanchet: Innovator in TNF-Modulating Therapeutics
Introduction
Marco Zanchet is a prominent inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Marco Zanchet holds a patent for "Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereof." This invention relates to phenyl-alkyl piperazines of a specific formula, which exhibit TNF-modulating activity. The patent encompasses the preparation of these compounds, their pharmaceutical compositions, and their therapeutic uses.
Career Highlights
Marco Zanchet is currently employed at Sanofi, a leading global healthcare company. His role involves research and development of new therapeutic agents that can improve patient outcomes. His expertise in pharmacology and medicinal chemistry has been instrumental in advancing the company's innovative projects.
Collaborations
Marco Zanchet collaborates with notable colleagues, including Marco Baroni and Olaf Ritzeler. These partnerships enhance the research efforts and contribute to the successful development of new therapeutic solutions.
Conclusion
Marco Zanchet's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to TNF-modulating therapeutics highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile